Cepheid is a molecular diagnostics company that develops, manufactures, and markets integrated systems for testing in the clinical and non-clinical markets. Its systems enable molecular testing for organisms and genetic-based diseases by automating manual laboratory procedures. The Company primarily offers GeneXpert system that integrates sample preparation in addition to DNA amplification and detection. The system is used for testing in the areas of healthcare-associated infections, critical infectious disease, sexual health, virology, oncology, and genetics. The Company also provides SmartCycler system, which integrates DNA amplification and detection to allow analysis of a sample, and Xpert tests for use on the GeneXpert system.

Type
Subsidiary
Parent Company
Danaher
HQ
Sunnyvale, US
Founded
1996
Cepheid was founded in 1996 and is headquartered in Sunnyvale, US
Report incorrect company information

Cepheid Office Locations

Cepheid has an office in Sunnyvale, Maurens-Scopont, São Paulo, Hong Kong and in 13 other locations
Sunnyvale, US (HQ)
904 Building 1 E Caribbean Dr
Banksmeadow, AU
Unit 3, 1 Anderson St
Lane Cove West, AU
23-27 Chaplin Drive
Geel, BE
Kleinhoefstraat 5 bus 26
São Paulo, BR
Rua Luigi Galvani 200 conjunto 51
Shanghai, CN
Suite 1806-1807 Hongwell International Plaza 1602 Zhong Shan West Road
Show all (17)
Report incorrect company information

Cepheid Financials and Metrics

Summary Metrics

Founding Date

1996

Total Funding

$27.1 m

Investors

Cepheid is a subsidiary of Danaher

Cepheid Financials

Cepheid's revenue was reported to be $538.58 m in FY, 2015 which is a 14.6% increase from the previous period.
Annual
USDFY, 2013FY, 2014FY, 2015

Revenue

401.3 m470.1 m538.6 m

Revenue growth, %

17%15%

Cost of goods sold

207.9 m229.3 m269.9 m

Gross profit

193.4 m240.8 m268.7 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

100.1 m106.9 m116.5 m115.2 m132.6 m132.5 m126.5 m144.8 m146 m158.5 m

Cost of goods sold

51.7 m53.1 m59.6 m56.8 m61.2 m69.4 m67.7 m72.6 m73.2 m83.4 m

Gross profit

48.4 m53.8 m56.9 m58.4 m71.4 m63.1 m58.8 m72.2 m72.8 m75.1 m

Gross profit Margin, %

48%50%49%51%54%48%46%50%50%47%
Annual
USDFY, 2013FY, 2014FY, 2015

Cash

66.1 m96.7 m112.6 m

Inventories

13 m24.3 m18.5 m

Current Assets

244 m519.1 m556.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

68.8 m136.7 m121 m134.7 m109.6 m110.6 m136.5 m89.8 m100.3 m115.7 m

Accounts Receivable

42 m56.6 m55.4 m55.8 m

Inventories

101.6 m119.6 m123.3 m128.3 m140.8 m142.1 m144.8 m150.4 m156.8 m155.7 m

Current Assets

234.1 m463.4 m504 m505 m555.1 m548.3 m562.4 m542 m566.5 m629.9 m
Annual
USDFY, 2013FY, 2014FY, 2015

Net Income

(18 m)(50.1 m)(48.5 m)

Inventories

(5.3 m)(5.2 m)(387 k)

Accounts Payable

17.3 m

Cash From Operating Activities

15 m9.2 m31.1 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015

Net Income

(1.4 m)(9.3 m)(9.8 m)(7.2 m)906 k
Show all financial metrics
Report incorrect company information